• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For February 27, 2023

    2/27/23 7:46:14 AM ET
    $AAON
    $ACAD
    $ACHC
    $ADUS
    Industrial Machinery/Components
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAON alert in real time by email

    Companies Reporting Before The Bell

    • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

    • Alcon (NYSE:ALC) is expected to report quarterly earnings at $0.88 per share on revenue of $205.25 million.

    • Itron (NASDAQ:ITRI) is estimated to report quarterly earnings at $0.09 per share on revenue of $433.64 million.

    • Fisker (NYSE:FSR) is expected to report quarterly loss at $0.42 per share on revenue of $2.51 million.

    • BGC Partners (NASDAQ:BGCP) is likely to report quarterly earnings at $0.16 per share on revenue of $422.99 million.

    • Tegna (NYSE:TGNA) is likely to report quarterly earnings at $1.13 per share on revenue of $963.23 million.

    • Nordic American Tankers (NYSE:NAT) is likely to report quarterly earnings at $0.19 per share on revenue of $73.67 million.

    • Harsco (NYSE:HSC) is estimated to report quarterly loss at $0.07 per share on revenue of $460.05 million.

    • Protalix BioTherapeutics (AMEX:PLX) is likely to report quarterly loss at $0.15 per share on revenue of $6.12 million.

    • Viatris (NASDAQ:VTRS) is estimated to report quarterly earnings at $0.72 per share on revenue of $3.98 billion.

    • FREYR Battery (NYSE:FREY) is likely to report earnings for its fourth quarter.

    • Li Auto (NASDAQ:LI) is projected to report quarterly earnings at $0.02 per share on revenue of $2.55 billion.

    • QuantaSing Group (NASDAQ:QSG) is likely to report earnings for its second quarter.

    • Lincoln Educational Servs (NASDAQ:LINC) is estimated to report quarterly earnings at $0.26 per share on revenue of $89.69 million.

    • Ready Capital (NYSE:RC) is likely to report quarterly earnings at $0.42 per share on revenue of $78.37 million.

    • FuboTV (NYSE:FUBO) is projected to report quarterly loss at $0.71 per share on revenue of $285.54 million.

    • Freshpet (NASDAQ:FRPT) is estimated to report quarterly loss at $0.09 per share on revenue of $152.11 million.

    • Global Partners (NYSE:GLP) is likely to report quarterly earnings at $1.40 per share on revenue of $4.51 billion.

    • Compugen (NASDAQ:CGEN) is projected to report earnings for its fourth quarter.

    • Opera (NASDAQ:OPRA) is likely to report quarterly earnings at $0.17 per share on revenue of $90.24 million.

    • LendingTree (NASDAQ:TREE) is likely to report quarterly loss at $0.34 per share on revenue of $208.14 million.

    • Pinnacle West Capital (NYSE:PNW) is projected to report quarterly loss at $0.18 per share on revenue of $638.28 million.

    • Axsome Therapeutics (NASDAQ:AXSM) is likely to report quarterly loss at $1.14 per share on revenue of $21.89 million.

    • Blackstone Secured (NYSE:BXSL) is estimated to report quarterly earnings at $0.88 per share on revenue of $246.76 million.

    • AES (NYSE:AES) is projected to report quarterly earnings at $0.46 per share on revenue of $2.99 billion.

    • Koppers Hldgs (NYSE:KOP) is likely to report quarterly earnings at $0.92 per share on revenue of $506.50 million.

    • Global Blue Gr Holding (NYSE:GB) is projected to report earnings for its third quarter.

    • Essential Utilities (NYSE:WTRG) is estimated to report quarterly earnings at $0.45 per share on revenue of $573.22 million.

    Companies Reporting After The Bell

    • Ovintiv (NYSE:OVV) is likely to report quarterly earnings at $2.58 per share on revenue of $3.45 billion.

    • Range Resources (NYSE:RRC) is estimated to report quarterly earnings at $1.18 per share on revenue of $973.55 million.

    • RLJ Lodging (NYSE:RLJ) is likely to report quarterly earnings at $0.00 per share on revenue of $304.05 million.

    • Ingevity (NYSE:NGVT) is estimated to report quarterly earnings at $0.87 per share on revenue of $392.90 million.

    • Heico (NYSE:HEI) is expected to report quarterly earnings at $0.69 per share on revenue of $588.75 million.

    • Hims & Hers Health (NYSE:HIMS) is likely to report quarterly loss at $0.07 per share on revenue of $161.17 million.

    • ONEOK (NYSE:OKE) is expected to report quarterly earnings at $1.03 per share on revenue of $6.03 billion.

    • Occidental Petroleum (NYSE:OXY) is expected to report quarterly earnings at $1.80 per share on revenue of $8.66 billion.

    • Theravance Biopharma (NASDAQ:TBPH) is estimated to report quarterly loss at $0.17 per share on revenue of $15.72 million.

    • Argo Gr Intl Hldgs (NYSE:ARGO) is likely to report quarterly loss at $1.75 per share on revenue of $469.95 million.

    • ACADIA Pharmaceuticals (NASDAQ:ACAD) is estimated to report quarterly loss at $0.24 per share on revenue of $134.07 million.

    • Vimeo (NASDAQ:VMEO) is expected to report quarterly loss at $0.15 per share on revenue of $105.00 million.

    • Inari Medical (NASDAQ:NARI) is projected to report quarterly loss at $0.17 per share on revenue of $104.84 million.

    • Biomarin Pharmaceutical (NASDAQ:BMRN) is expected to report quarterly loss at $0.07 per share on revenue of $536.97 million.

    • CareDx (NASDAQ:CDNA) is expected to report quarterly loss at $0.09 per share on revenue of $81.66 million.

    • Vaxcyte (NASDAQ:PCVX) is projected to report earnings for its fourth quarter.

    • ARKO (NASDAQ:ARKO) is estimated to report quarterly earnings at $0.09 per share on revenue of $2.21 billion.

    • Innovative Ind Props (NYSE:IIPR) is estimated to report earnings for its fourth quarter.

    • NewtekOne (NASDAQ:NEWT) is likely to report quarterly earnings at $0.63 per share on revenue of $24.77 million.

    • Diamond Offshore Drilling (NYSE:DO) is estimated to report quarterly loss at $0.32 per share on revenue of $211.00 million.

    • Emergent BioSolutions (NYSE:EBS) is expected to report quarterly earnings at $0.04 per share on revenue of $296.62 million.

    • National Storage (NYSE:NSA) is projected to report earnings for its fourth quarter.

    • Kinetik Holdings (NYSE:KNTK) is likely to report quarterly earnings at $0.66 per share on revenue of $259.42 million.

    • Tidewater (NYSE:TDW) is projected to report quarterly earnings at $0.23 per share on revenue of $196.20 million.

    • 180 Degree Capital (NASDAQ:TURN) is expected to report earnings for its fourth quarter.

    • Woodside Energy Group (NYSE:WDS) is likely to report earnings for its Fiscal Year 2022.

    • Rover Group (NASDAQ:ROVR) is projected to report quarterly earnings at $0.00 per share on revenue of $50.15 million.

    • Revolution Medicines (NASDAQ:RVMD) is likely to report quarterly loss at $0.82 per share on revenue of $7.75 million.

    • Rayonier Adv Materials (NYSE:RYAM) is likely to report quarterly earnings at $0.04 per share on revenue of $436.36 million.

    • FibroGen (NASDAQ:FGEN) is estimated to report quarterly loss at $0.94 per share on revenue of $24.04 million.

    • Agora (NASDAQ:API) is likely to report quarterly loss at $0.14 per share on revenue of $40.00 million.

    • Hyster-Yale Materials (NYSE:HY) is expected to report quarterly loss at $0.22 per share on revenue of $892.55 million.

    • Sterling Infrastructure (NASDAQ:STRL) is likely to report quarterly earnings at $0.68 per share on revenue of $437.73 million.

    • Broadmark Realty Capital (NYSE:BRMK) is estimated to report quarterly earnings at $0.12 per share on revenue of $25.92 million.

    • Darling Ingredients (NYSE:DAR) is projected to report quarterly earnings at $1.34 per share on revenue of $1.70 billion.

    • Summit Hotel Properties (NYSE:INN) is estimated to report quarterly loss at $0.02 per share on revenue of $169.17 million.

    • Titan Intl (NYSE:TWI) is expected to report quarterly earnings at $0.44 per share on revenue of $523.30 million.

    • Universal Health Services (NYSE:UHS) is likely to report quarterly earnings at $2.96 per share on revenue of $3.40 billion.

    • Asure Software (NASDAQ:ASUR) is likely to report quarterly earnings at $0.00 per share on revenue of $23.73 million.

    • Progyny (NASDAQ:PGNY) is estimated to report quarterly earnings at $0.01 per share on revenue of $211.78 million.

    • Green Brick Partners (NYSE:GRBK) is projected to report quarterly earnings at $1.14 per share on revenue of $356.57 million.

    • TTEC Holdings (NASDAQ:TTEC) is projected to report quarterly earnings at $0.74 per share on revenue of $629.25 million.

    • PRA Group (NASDAQ:PRAA) is projected to report quarterly earnings at $0.32 per share on revenue of $219.13 million.

    • James River Gr Hldgs (NASDAQ:JRVR) is likely to report quarterly earnings at $0.52 per share on revenue of $212.47 million.

    • Ameresco (NYSE:AMRC) is estimated to report quarterly earnings at $0.39 per share on revenue of $366.59 million.

    • Heidrick & Struggles Intl (NASDAQ:HSII) is expected to report quarterly earnings at $0.63 per share on revenue of $222.05 million.

    • Workday (NASDAQ:WDAY) is estimated to report quarterly earnings at $0.91 per share on revenue of $1.63 billion.

    • Perrigo (NYSE:PRGO) is projected to report quarterly earnings at $0.69 per share on revenue of $1.19 billion.

    • Clarus (NASDAQ:CLAR) is likely to report quarterly earnings at $0.22 per share on revenue of $101.00 million.

    • TaskUs (NASDAQ:TASK) is expected to report quarterly earnings at $0.32 per share on revenue of $232.16 million.

    • Establishment Labs Hldgs (NASDAQ:ESTA) is likely to report quarterly loss at $0.68 per share on revenue of $43.27 million.

    • Primoris Services (NASDAQ:PRIM) is estimated to report quarterly earnings at $0.72 per share on revenue of $1.31 billion.

    • SI-BONE (NASDAQ:SIBN) is expected to report quarterly loss at $0.40 per share on revenue of $31.22 million.

    • Trex Co (NYSE:TREX) is likely to report quarterly earnings at $0.21 per share on revenue of $185.25 million.

    • Zoom Video Comms (NASDAQ:ZM) is expected to report quarterly earnings at $0.80 per share on revenue of $1.10 billion.

    • ViewRay (NASDAQ:VRAY) is projected to report quarterly loss at $0.16 per share on revenue of $33.89 million.

    • Acadia Healthcare Co (NASDAQ:ACHC) is estimated to report quarterly earnings at $0.75 per share on revenue of $660.42 million.

    • Addus HomeCare (NASDAQ:ADUS) is likely to report quarterly earnings at $0.95 per share on revenue of $246.15 million.

    • MKS Instruments (NASDAQ:MKSI) is expected to report quarterly earnings at $1.34 per share on revenue of $994.02 million.

    • Helios Technologies (NYSE:HLIO) is estimated to report quarterly earnings at $0.75 per share on revenue of $208.67 million.

    • ICU Medical (NASDAQ:ICUI) is expected to report quarterly earnings at $1.56 per share on revenue of $578.77 million.

    • AAON (NASDAQ:AAON) is estimated to report quarterly earnings at $0.56 per share on revenue of $240.28 million.

    • EverQuote (NASDAQ:EVER) is expected to report quarterly loss at $0.27 per share on revenue of $90.24 million.

    • Banco Latinoamericano (NYSE:BLX) is likely to report quarterly earnings at $0.65 per share on revenue of $42.20 million.

    • QuickLogic (NASDAQ:QUIK) is likely to report quarterly loss at $0.05 per share on revenue of $4.33 million.

    • FS KKR Capital (NYSE:FSK) is projected to report quarterly earnings at $0.73 per share on revenue of $431.57 million.

    • Tetra Technologies (NYSE:TTI) is expected to report quarterly earnings at $0.03 per share on revenue of $135.50 million.

    • New Mountain Finance (NASDAQ:NMFC) is estimated to report quarterly earnings at $0.35 per share on revenue of $82.64 million.

    • CrossAmerica Partners (NYSE:CAPL) is expected to report quarterly earnings at $0.17 per share on revenue of $725.28 million.

    • Carlyle Secured Lending (NASDAQ:CGBD) is projected to report quarterly earnings at $0.46 per share on revenue of $54.60 million.

    • ProAssurance (NYSE:PRA) is expected to report quarterly earnings at $0.15 per share on revenue of $220.26 million.

    • Howard Hughes (NYSE:HHC) is likely to report quarterly earnings at $0.97 per share on revenue of $442.90 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AAON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAON
    $ACAD
    $ACHC
    $ADUS

    CompanyDatePrice TargetRatingAnalyst
    The AES Corporation
    $AES
    2/27/2026Sell → Neutral
    Seaport Research Partners
    Revolution Medicines Inc.
    $RVMD
    2/27/2026$145.00Buy
    UBS
    Heico Corporation
    $HEI
    2/27/2026Neutral → Outperform
    BNP Paribas Exane
    Alcon Inc.
    $ALC
    2/26/2026$97.00Equal Weight → Overweight
    Wells Fargo
    Carlyle Secured Lending Inc.
    $CGBD
    2/25/2026$13.00Neutral → Buy
    B. Riley Securities
    ONEOK Inc.
    $OKE
    2/25/2026Outperform → Peer Perform
    Wolfe Research
    Ovintiv Inc. (DE)
    $OVV
    2/25/2026$58.00Overweight
    Analyst
    Workday Inc.
    $WDAY
    2/25/2026$160.00Outperform → In-line
    Evercore ISI
    More analyst ratings

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director George Walter N. bought $49,795 worth of shares (630 units at $79.04), increasing direct ownership by 1% to 47,157 units (SEC Form 4)

    4 - Freshpet, Inc. (0001611647) (Issuer)

    2/26/26 4:07:13 PM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    Director Mccallister Terry D bought $1,643 worth of shares (12 units at $138.00), increasing direct ownership by 0.06% to 20,552 units (SEC Form 4)

    4 - Primoris Services Corp (0001361538) (Issuer)

    1/16/26 6:05:05 PM ET
    $PRIM
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    General Partner Global Gp Llc bought $185,507 worth of Common units representing limited partner interests (4,330 units at $42.84), increasing direct ownership by 2% to 230,273 units (SEC Form 4)

    4 - GLOBAL PARTNERS LP (0001323468) (Issuer)

    12/23/25 4:57:26 PM ET
    $GLP
    Oil Refining/Marketing
    Energy

    $AAON
    $ACAD
    $ACHC
    $ADUS
    SEC Filings

    View All

    Pinnacle West Capital Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - PINNACLE WEST CAPITAL CORP (0000764622) (Filer)

    2/27/26 5:29:07 PM ET
    $PNW
    Electric Utilities: Central
    Utilities

    SEC Form 10-K filed by Zoom Communications Inc.

    10-K - Zoom Communications, Inc. (0001585521) (Filer)

    2/27/26 5:18:02 PM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    SEC Form S-8 filed by Establishment Labs Holdings Inc.

    S-8 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)

    2/27/26 5:04:50 PM ET
    $ESTA
    Industrial Specialties
    Health Care

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AES upgraded by Seaport Research Partners

    Seaport Research Partners upgraded AES from Sell to Neutral

    2/27/26 12:32:09 PM ET
    $AES
    Electric Utilities: Central
    Utilities

    UBS resumed coverage on Revolution Medicines with a new price target

    UBS resumed coverage of Revolution Medicines with a rating of Buy and set a new price target of $145.00

    2/27/26 8:31:41 AM ET
    $RVMD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    HEICO upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded HEICO from Neutral to Outperform

    2/27/26 8:21:04 AM ET
    $HEI
    Aerospace
    Industrials

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

    Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS studyPALYNZIQ is the only enzyme substitution therapy approved for the treatment of people with PKUSAN RAFAEL, Calif., Feb. 27, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® (pegvaliase-pqpz) to include pediatric patients 12 years of age and older with phenylketonuria (PKU). PALYNZIQ is the only enzyme substitution therapy approved to reduce blood phenylalanine (Phe) concentrations

    2/27/26 8:00:00 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Global Partners LP Files 2025 Annual Report on Form 10-K

    Global Partners LP (NYSE:GLP) ("Global Partners" or the "Partnership") today announced that its Annual Report on Form 10-K for the year ended December 31, 2025, was filed with the U.S. Securities and Exchange Commission ("SEC") on February 27, 2026. A copy of the Annual Report on Form 10-K is available to be viewed or downloaded from the "SEC Filings" page of the Partnership's investor relations website or from the SEC's website at www.sec.gov. A hard copy of the Partnership's complete audited financial statements also can be obtained free of charge by contacting the Global Partners Investor Relations department at (857) 383-2409 or emailing [email protected]. About Global Partn

    2/27/26 4:05:00 PM ET
    $GLP
    Oil Refining/Marketing
    Energy

    CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CareDx, Inc. (NASDAQ:CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants. On February 24, 2026, as an inducement material to acceptance of employment with CareDx, 35 new employees were awarded restricted stock units (RSUs) for an aggregate of 82,137 shares of common stock. The RSU awards were made pursuant to the Company's 2016 and 2025 Inducement Equity Incentive Plans in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, wit

    2/27/26 4:01:00 PM ET
    $CDNA
    Medical Specialities
    Health Care

    $AAON
    $ACAD
    $ACHC
    $ADUS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-9) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 210793, Application Classification: Efficacy

    9/18/23 10:47:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-12) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 207318, Application Classification: Efficacy

    9/18/23 10:40:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    July 13, 2023 - FDA Approves First Nonprescription Daily Oral Contraceptive

    For Immediate Release: July 13, 2023 Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for use in the U.S. without a prescription. Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stor

    7/13/23 8:32:15 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and General Counsel Corrsin David J exercised 20,000 shares at a strike of $4.64, increasing direct ownership by 4,246% to 20,471 units (SEC Form 4)

    4 - Ameresco, Inc. (0001488139) (Issuer)

    2/27/26 7:42:15 PM ET
    $AMRC
    Engineering & Construction
    Consumer Discretionary

    SEC Form 4 filed by Chief Executive Officer Tabuteau Herriot

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    2/27/26 7:10:09 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by General Counsel Murdock Hunter R.

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    2/27/26 7:10:06 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Leadership Updates

    Live Leadership Updates

    View All

    Ready Capital Corporation Announces Leadership Changes

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ready Capital Corporation (NYSE:RC) (the "Company") today announced the appointment of Dominick Scali as Chief Credit Officer of the Company and Co-President of ReadyCap Commercial, LLC, the Company's commercial real estate lending business. Mr. Scali has been a Managing Director and Co-Head of Bridge Lending with the Company since 2015. Prior to that, he was head of credit and underwriting for Doral Bank's national bridge lending platform and held positions in credit and originations at Anglo Irish bank. He began his career at Citigroup working within Citibank's affordable housing department. Mr. Scali holds a B.A. from Columbia University. Ad

    2/26/26 4:25:00 PM ET
    $RC
    Real Estate Investment Trusts
    Real Estate

    CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer

    Kennedy brings seven years of public company CFO experience CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced that Keith Kennedy, the Company's Chief Operating Officer (COO), will also assume the responsibilities of Chief Financial Officer (CFO) and oversee the Company's finance organization effective February 26, 2026. Kennedy brings to CareDx over 20 years of experience and executive leadership in healthcare including global diagnostics, biopharma services, and contrac

    2/24/26 5:15:00 PM ET
    $CDNA
    Medical Specialities
    Health Care

    Establishment Labs Announces Leadership Transition to Support Next Phase of Growth

    Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic leadership transition of Raj Denhoy, current Chief Financial Officer to Senior Vice President, Global Strategy, and the appointment of Cassandra "Sandra" Harris to Senior Vice President and Chief Financial Officer, effective March 9, 2026. "Over the past few years, we have been focused on driving efficient execution and scalability. With the company well positioned for its next chapter of growth, we are creating additional leadership capacity to maintain operational momentum

    2/24/26 8:00:00 AM ET
    $ESTA
    $GCO
    Industrial Specialties
    Health Care
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Financials

    Live finance-specific insights

    View All

    Global Partners Reports Fourth-Quarter and Full-Year 2025 Financial Results

    Global Partners LP (NYSE:GLP) ("Global Partners" or the "Partnership") today reported financial results for the fourth quarter and full year ended December 31, 2025. CEO Commentary "We closed 2025 with a fourth quarter that reflected the strength and resilience of our integrated platform," said Eric Slifka, President and Chief Executive Officer. "Built and refined over more than 90 years, our diversified business model and broad network provide a durable competitive advantage, positioning us to navigate market cycles and adapt to dynamic market conditions while meeting the needs of the markets, customers and communities we serve. "The flexibility of our business model was reflected in

    2/27/26 8:00:00 AM ET
    $GLP
    Oil Refining/Marketing
    Energy

    AES Reschedules Fourth Quarter & Full Year 2025 Financial Review Conference Call to March 3, 2026

    ARLINGTON, Va., Feb. 27, 2026 /PRNewswire/ -- The AES Corporation (NYSE:AES) rescheduled its fourth quarter and full year 2025 financial review conference call, which was previously scheduled for Friday, February 27, 2026.  The Company will now hold this call on Tuesday, March 3, 2026 at 10:00 a.m. Eastern Time (ET), following the filing of its Annual Report on Form 10-K on Monday, March 2, 2026.     The call will include prepared remarks and a question and answer session.  It will be open to the media and the public in a listen-only mode by telephone and webcast.  Interested pa

    2/27/26 7:00:00 AM ET
    $AES
    Electric Utilities: Central
    Utilities

    Range Increases Quarterly Dividend By 11%

    FORT WORTH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE:RRC) today announced that its Board of Directors declared a quarterly cash dividend on its common stock for the first quarter. A dividend of $0.10 per common share is payable on March 27, 2026 to stockholders of record at the close of business on March 13, 2026. This represents an 11% increase to Range's quarterly cash dividend and provides an annualized dividend of $0.40 per share. RANGE RESOURCES CORPORATION (NYSE:RRC) is a leading U.S. independent natural gas and NGL producer with operations focused in the Appalachian Basin. The Company is headquartered in Fort Worth, Texas.  More information about R

    2/27/26 7:00:00 AM ET
    $RRC
    Oil & Gas Production
    Energy

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Progyny Inc.

    SC 13G/A - Progyny, Inc. (0001551306) (Subject)

    12/6/24 10:11:35 AM ET
    $PGNY
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Opera Limited

    SC 13D/A - Opera Ltd (0001737450) (Subject)

    12/6/24 6:15:42 AM ET
    $OPRA
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Global Blue Group Holding AG

    SC 13D/A - Global Blue Group Holding AG (0001799983) (Subject)

    12/5/24 6:24:01 AM ET
    $GB
    EDP Services
    Technology